These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10917395)

  • 1. Methadone withdrawal symptoms with nevirapine and efavirenz.
    Pinzani V; Faucherre V; Peyriere H; Blayac JP
    Ann Pharmacother; 2000 Mar; 34(3):405-7. PubMed ID: 10917395
    [No Abstract]   [Full Text] [Related]  

  • 2. Nevirapine and methadone withdrawal.
    AIDS Patient Care STDS; 1999 Aug; 13(8):504. PubMed ID: 10800532
    [No Abstract]   [Full Text] [Related]  

  • 3. Undefined duration of opiate withdrawal induced by efavirenz in drug users with HIV infection and undergoing chronic methadone treatment.
    Boffito M; Rossati A; Reynolds HE; Hoggard PG; Back DJ; Di Perri G
    AIDS Res Hum Retroviruses; 2002 Mar; 18(5):341-2. PubMed ID: 11897035
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment: opiate withdrawal symptoms induced by antiretroviral drugs.
    Eap CB
    Ann Pharmacother; 2000 Sep; 34(9):1077-8. PubMed ID: 10981259
    [No Abstract]   [Full Text] [Related]  

  • 5. Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert.
    Otero MJ; Fuertes A; Sánchez R; Luna G
    AIDS; 1999 May; 13(8):1004-5. PubMed ID: 10371190
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?
    Soriano V; Dona C; Barreiro P; González-Lahoz J
    AIDS; 2000 Jul; 14(11):1672-3. PubMed ID: 10983663
    [No Abstract]   [Full Text] [Related]  

  • 7. NNRTI hepatotoxicity: efavirenz versus nevirapine.
    Pulido F; Torralba M
    J HIV Ther; 2002 Nov; 7 Suppl 2():S3-16. PubMed ID: 12735215
    [No Abstract]   [Full Text] [Related]  

  • 8. Efavirenz decreases methadone blood concentrations.
    Marzolini C; Troillet N; Telenti A; Baumann P; Decosterd LA; Eap CB
    AIDS; 2000 Jun; 14(9):1291-2. PubMed ID: 10894303
    [No Abstract]   [Full Text] [Related]  

  • 9. Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone.
    Altice FL; Friedland GH; Cooney EL
    AIDS; 1999 May; 13(8):957-62. PubMed ID: 10371177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nevirapine induces abstinence symptoms in patients on a methadone maintenance program with HIV infection].
    Baño Rodrigo MD; Agujetas Rodríguez M; López García ML; Guillén Llera JL
    Rev Clin Esp; 2000 Jan; 200(1):12-4. PubMed ID: 10721283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone withdrawal when starting an antiretroviral regimen including nevirapine.
    Heelon MW; Meade LB
    Pharmacotherapy; 1999 Apr; 19(4):471-2. PubMed ID: 10212021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone and anti-HIV drugs.
    Fornataro K
    Body Posit; 1999 May; 12(5):13. PubMed ID: 11366305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of methadone plasma concentration measurement in patients receiving nevirapine or efavirenz.
    Pelet A; Favrat B; Cavassini M; Eap CB; Besson J; Monnat M
    Am J Drug Alcohol Abuse; 2011 Jul; 37(4):264-8. PubMed ID: 21699349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interaction between methadone and antiretrovirals (stavudine, indinavir, ritonavir, nevirapine)].
    de la Cruz Pellín M; Esteban J; Gimeno C; Mora E
    Med Clin (Barc); 2003 Oct; 121(11):439. PubMed ID: 14563283
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk and determinants of developing severe liver toxicity during therapy with nevirapine-and efavirenz-containing regimens in HIV-infected patients.
    Ena J; Amador C; Benito C; Fenoll V; Pasquau F
    Int J STD AIDS; 2003 Nov; 14(11):776-81. PubMed ID: 14624743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of R-/S-methadone enantiomer concentration ratio in serum of patients treated with either nevirapine or efavirenz.
    Esteban J; Pellín Mde L; Gimeno C; Barril J; Giménez J; Mora E; Garcia-Pérez AG
    Drug Metab Lett; 2008 Dec; 2(4):269-79. PubMed ID: 19356104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors of rash associated with efavirenz in HIV-infected patients with preceding nevirapine-associated rash.
    Manosuthi W; Thongyen S; Chumpathat N; Muangchana K; Sungkanuparph S
    HIV Med; 2006 Sep; 7(6):378-82. PubMed ID: 16903982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase efavirenz.
    Calvo R; Lukas JC; Rodriguez M; Carlos MA; Suarez E
    Br J Clin Pharmacol; 2002 Feb; 53(2):212-4. PubMed ID: 11851649
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection].
    van Leth F; Lange JM
    Ned Tijdschr Geneeskd; 2006 Aug; 150(31):1719-22. PubMed ID: 16924943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues in antiretroviral toxicity.
    Boyle BA
    AIDS Read; 2003 Oct; 13(10):459, 463-4, 468-9, 479. PubMed ID: 14596223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.